Detail akcie Stev Grp Rg online

Business Summary: Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Stevanato Group SpA revenues increased 9% to EUR839.8M. Net income applicable to common stockholders increased 33% to EUR92.3M. Revenues reflect Biopharmaceutical and Diagnostic Solutions segment increase of 12% to EUR731.1M, North America segment increase of 18% to EUR246.8M, EMEA segment increase of 5% to EUR500.1M, APAC segment increase of 7% to EUR69.5M.